Alves, C. L., Ehmsen, S., Terp, M. G., Portman, N., Tuttolomondo, M., Gammelgaard, O. L., . . . Ditzel, H. J. (2021). Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationAlves, Carla L., et al. Publisher Correction: Co-targeting CDK4/6 and AKT with Endocrine Therapy Prevents Progression in CDK4/6 Inhibitor and Endocrine Therapy-resistant Breast Cancer. Nature Portfolio, 2021.
MLA (8th ed.) CitationAlves, Carla L., et al. Publisher Correction: Co-targeting CDK4/6 and AKT with Endocrine Therapy Prevents Progression in CDK4/6 Inhibitor and Endocrine Therapy-resistant Breast Cancer. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.